Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Cancer Research

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-3329PMID 19509139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling Pathway

  2009cited by this paper
• DBC1 is a negative regulator of SIRT1

  2008cited by this paper
• Negative regulation of the deacetylase SIRT1 by DBC1

  2008cited by this paper
• SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma

  2008cited by this paper
• Cytoplasm‐localized SIRT1 enhances apoptosis

  2007cited by this paper
• Modulation of estrogen receptor alpha protein level and survival function by DBC-1.

  2007cited by this paper
• SIRT 1 Is Significantly Elevated in Mouse and Human Prostate Cancer

  2007cited by this paper
• Human SIRT1: A potential biomarker for tumorigenesis?

  2007cited by this paper
• Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.

  2007cited by this paper
• Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease

  2007cited by this paper
• Modulation of estrogen receptor α protein level and survival function by DBC-1

  2007cited by this paper
• Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.

  2007cited by this paper
• Sirtuins: critical regulators at the crossroads between cancer and aging

  2007cited by this paper
• SIRT1 is significantly elevated in mouse and human prostate cancer.

  2007cited by this paper
• Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

  2006cited by this paper
• Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1.

  2006cited by this paper
• Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.

  2005cited by this paper
• Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.

  2005cited by this paper
• Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

  2005cited by this paper
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

  2005cited by this paper
• Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

  2005cited by this paper
• Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice.

  2005cited by this paper
• Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

  2005cited by this paper
• Role of NAD‐dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin‐induced cell death in vertebrate cells

  2005cited by this paper
• Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.

  2005cited by this paper
• Gene Expression in the Urinary Bladder

  2004cited by this paper
• Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.

  2004cited by this paper
• Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative Carcinoma

  2004cited by this paper
• EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.

  2004cited by this paper
• The Sir2 family of protein deacetylases.

  2004cited by this paper
• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

  2004cited by this paper
• Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase

  2004cited by this paper
• Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• DBC2, a candidate for a tumor suppressor gene involved in breast cancer

  2002cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Cancer Statistics, 2002

  2002cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

  2000cited by this paper
• Pathology and genetics of tumours of the digestive system

  2000cited by this paper
• Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

  1993cited by this paper
• Estimates of the worldwide incidence of eighteen major cancers in 1985

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Transcriptional silencing and longevity protein Sir 2 is an NAD-dependent histone deacetylase

  year unknowncited by this paper

• The role of SIRT1 in the development of gastrointestinal tumors

  2025cites this paper
• CCAR2 Drives Glioma Cell Survival by Positively Regulating SIRT1 and Activating the Notch1/c‐Myc Pathway

  2025cites this paper
• Prognostic and clinicopathological value of dbc1 expression in human cancers: a systematic review and meta-analysis

  2025cites this paper
• Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism

  2024cites this paper
• Current development of molecular classifications of gastric cancer based on omics (Review)

  2024cites this paper
• ATGL promotes colorectal cancer growth by regulating autophagy process and SIRT1 expression

  2023cites this paper
• Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer

  2023cites this paper
• A strategy for the treatment of gastrointestinal cancer: Targeting tumor senescent cells

  2023cites this paper
• Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer

  2023cites this paper
• Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

  2023cites this paper
• Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation

  2022cites this paper
• miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs

  2022cites this paper
• Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?

  2022influential citation
• SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

  2022cites this paper
• Sirtuins (SIRTs) As a Novel Target in Gastric Cancer

  2022cites this paper
• Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators

  2021cites this paper
• Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism

  2021cites this paper
• Sirtuins as NAD+-dependent deacetylases and their potential in medical therapy

  2021cites this paper
• SIRT1 Contributes as an Invasiveness Marker in Pituitary Adenoma

  2021cites this paper
• Circ-sirt1 inhibits growth and invasion of gastric cancer by sponging and upregulating

  2021cites this paper
• Associations of sirtuins with clinicopathological variables and prognosis in human ovarian cancer

  2020cites this paper
• Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective

  2020cites this paper
• CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis

  2020cites this paper
• STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects

  2020cites this paper
• p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2

  2020cites this paper
• SIRT1 promotes EMT, migration and invasion by regulating mTORC1/4E-BP1 in colorectal cancer

  2020cites this paper
• Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy

  2020cites this paper
• Sirtuins as Drug Targets

  2019cites this paper
• Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis

  2019influential citation
• SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism

  2019cites this paper
• CMAR_A_211122 8419..8429

  2019cites this paper
• SIRT1: a potential tumour biomarker and therapeutic target

  2019cites this paper
• MicroRNA‑506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1

  2019cites this paper
• The Roles of Sirtuin Family Proteins in Cancer Progression

  2019cites this paper
• sirT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism

  2019cites this paper
• SIRT1 (rs3740051) role in pituitary adenoma development

  2019cites this paper
• DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination

  2019cites this paper
• Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis

  2019cites this paper
• Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling

  2019cites this paper
• A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo

  2019cites this paper
• SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP‐13 signaling

  2019cites this paper
• Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients

  2019influential citation
• The sirtuin family in cancer

  2019cites this paper
• SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma

  2019cites this paper
• Determination of SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, and RAGE rs1800625 Single Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma

  2019cites this paper
• ZNF326 promotes a malignant phenotype of breast cancer by interacting with DBC1

  2018cites this paper
• The clinicopathological significance of SIRT1 expression in colon cancer: An immunohistochemical study and meta-analysis.

  2018cites this paper
• Expression of oxidized protein tyrosine phosphatase and γH2AX predicts poor survival of gastric carcinoma patients

  2018cites this paper
• Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer

  2018cites this paper
• SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma

  2018cites this paper
• Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest

  2018cites this paper
• Is co-expression of USP22 and HSP90 more effective in predicting prognosis of gastric cancer?

  2018cites this paper
• NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN-45 cells.

  2018cites this paper
• The effect of centromere protein U silencing by lentiviral mediated RNA interference on the proliferation and apoptosis of breast cancer.

  2018cites this paper
• Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial–mesenchymal transition in cancer cells

  2018cites this paper
• The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells

  2018cites this paper
• Leptin induces SIRT1 expression through activation of NF‐E2‐related factor 2: Implications for obesity‐associated colon carcinogenesis☆

  2018cites this paper
• SIRT 4 is upregulated in breast cancer and promotes the proliferation , migration and invasion of breast cancer cells

  2017cites this paper
• The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis

  2017cites this paper
• SIRT4 is upregulated in breast cancer and promotes the proliferation, migration and invasion of breast cancer cells.

  2017cites this paper
• CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.

  2017cites this paper
• Effect of Sirtuin 1 inhibition on matrix metalloproteinase 2 and Forkhead box O3a expression in breast cancer cells

  2017cites this paper
• Meta-analysis of SIRT1 expression as a prognostic marker for overall survival in gastrointestinal cancer

  2017influential citation
• Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients

  2017influential citation
• Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1

  2017cites this paper
• SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma

  2017cites this paper
• Decreased SIRT4 protein levels in endometrioid adenocarcinoma tissues are associated with advanced AJCC stage

  2017cites this paper
• Expression of Silent Information Regulator-1(Sirt1), CD163 and Tryptase; Implications for Immune Dys-regulation, Prognosis and Therapeutic Targeting in Classical Hodgkin Lymphoma

  2017cites this paper
• Association of FGFR2 rs2981582, SIRT1 rs12778366, STAT3 rs744166 gene polymorphisms with pituitary adenoma

  2017cites this paper
• CCAR2 negatively regulates IL-8 production in cervical cancer cells

  2017cites this paper
• SIRT 1 and tumor resistance

  2017cites this paper
• Individual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients

  2017cites this paper
• Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma

  2017cites this paper
• Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer

  2017cites this paper
• Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.

  2017cites this paper
• Increased SIRT 7 protein levels predict a poor prognosis for patients with esophageal squamous cell carcinoma

  2017cites this paper
• Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.

  2017cites this paper
• SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma.

  2017cites this paper
• SIRT 4 protein levels are downregulated in kidney renal clear cell carcinoma

  2017cites this paper
• Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

  2016cites this paper
• Association of SIRT1 and HMGA1 expression in non-small cell lung cancer.

  2016cites this paper
• Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis

  2016cites this paper
• Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.

  2016cites this paper
• Expression of SIRT 1 , H 3 K 9 me 3 , H 3 K 9 Ac and E-cadherin and its correlations with clinicopathological characteristics in gastric cancer patients

  2016cites this paper
• NAD + -Dependent Deacetylases and Medical Therapy

  2016cites this paper
• Prognostic and Predictive Role of Sirtuin1 Expression in Lung Adenocarcinoma.

  2016cites this paper
• Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.

  2016cites this paper
• The Prognostic Role of SIRT1-Autophagy Axis in Gastric Cancer

  2016cites this paper
• CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients.

  2016cites this paper
• Depression accelerates the development of gastric cancer through reactive oxygen species‑activated ABL1 (Review).

  2016cites this paper
• Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians

  2016cites this paper
• The expression of SIRT 7 was down-regulated and correlated with tumor size in thyroid carcinoma

  2016cites this paper
• Molecular and Cellular Changes During Cancer Progression Resulting From Genetic and Epigenetic Alterations.

  2016cites this paper
• Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

  2016cites this paper
• Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis

  2016cites this paper
• SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment

  2015influential citation
• High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factors.

  2015cites this paper
• DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity.

  2015cites this paper
• CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase.

  2015cites this paper
• The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma

  2015influential citation